Phong Phu Pharmaceutical's mid-year profit surges 26%

Phong Phu Pharmaceutical Joint Stock Company reported a 26.57% increase in net profit after tax to VND 9.44 billion for the first six months of 2025, up from VND 7.46 billion in 2024.

Consolidated net profit rose 22.54% to VND 8.85 billion. The growth was driven by a 116% increase in financial income and cost reductions, with cost of goods sold falling 1.6% as a percentage of revenue for individual statements and 3.9% for consolidated statements.